Fortitude Family Office »

Crescent Biopharma shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2026-03-31 $735 40 18.38

More positions owned by Fortitude Family Office

Ishares Core S&p 500 Etf Etf (IVV)
Avantis Total Equity Markets Etf Etf (AVTM)
Vanguard 0-3 Month Treasury Bill Etf Etf (VBIL)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Apple Stock (AAPL)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Mid-cap Etf Etf (VO)
Vanguard S&p 500 Etf Etf (VOO)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Invesco Senior Loan Etf Etf (BKLN)
Avantis International Small Cap Value Etf Etf (AVDV)

View all positions for Fortitude Family Office

Top funds holding Crescent Biopharma

FMR
BVF
Fairmount Funds Management
VR Adviser
Fcpm Iii Services B.v.
Balyasny Asset Management
Vestal Point Capital
Opaleye Management
Tang Capital Management
Vanguard Capital Management
Vanguard Group
Logos Global Management
Deep Track Capital
Boxer Capital Management
Rtw Investments

View all funds holding Crescent Biopharma